Quick facts
Research Use Only
Phase 2 Complete
What is Fasoracetam?
Fasoracetam is an investigational compound belonging to the racetam family of cognitive enhancers. It was originally developed in Japan for vascular dementia. Researchers are studying how Fasoracetam might interact with multiple neurotransmitter systems in the brain, including glutamate and GABA, to support focus, memory, and mood, particularly in individuals with ADHD or cognitive decline.
Common Uses
In clinical trials, Fasoracetam was associated with improved focus and attention in adolescents with ADHD and specific genetic mutations.
Research suggests Fasoracetam acts on brain pathways to support memory formation and cognitive function.
Clinical research indicates Fasoracetam may support a balanced mood and reduce anxiety by modulating GABA receptors.
Fasoracetam has been studied for its potential to support cognitive function in individuals with age-related cognitive decline.
Studies & Clinical Research
Fasoracetam is an investigational compound studied for its effects on brain function. In research, Fasoracetam was associated with improved focus, memory, and mood by interacting with multiple neurotransmitter systems.
In clinical trials, some effects of Fasoracetam on focus and mood were reported relatively quickly, while broader cognitive benefits were observed with consistent use over weeks. Individual results vary.
In clinical trials, tesamorelin was associated with significant reductions in visceral fat over 26 to 52 weeks of treatment. Consistent use is required to maintain results.
Yes. Fasoracetam is an investigational compound and is not FDA-approved. A licensed healthcare provider should review your health history before you consider Fasoracetam.
Have a question you don’t see answered?
Ready to take the next step?
Find a verified peptide therapy provider or list your practice and connect with patients actively seeking trusted care.